Physician

Andrea T Dellaria, MD

According to 2025 Medicare claims, Andrea Dellaria, MD (NPI: 1982036182) practices neurology in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is NORTHWEST NEUROLOGY, LTD (NPI: 1427094077; TIN: 363329019) and primary practice location at 60048-5284. Dellaria is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Dellaria's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 75,722 HCPCS/CPT codes, and received $257,865 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,099 prescription claims across 558 beneficiaries totaling $453,164 in drug costs, led by Rebif (Interferon Beta-1a/Albumin). 2022 DME data shows 12 claims. Open Payments data shows 34 records totaling $801. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $33,229 to $257,865. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,836 and ending at $453,164. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	207	296	$33,229
2019	401	677	$69,767
2020	366	2,337	$95,579
2021	446	5,218	$213,716
2022	412	4,363	$170,673
2023	453	5,746	$173,515
2024	496	75,722	$257,865

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	107	$3,836
2016	43	136	$4,289
2017	89	325	$157,836
2018	178	678	$695,421
2019	222	716	$458,162
2020	239	814	$441,009
2021	370	1,181	$465,268
2022	442	1,425	$313,478
2023	436	1,564	$281,912
2024	558	2,099	$453,164

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$838
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	113	113	$167
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	252	335	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	230	282	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	69	84	$65
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	99	216	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rebif	Interferon Beta-1a/Albumin	22	616	$227,961
Memantine Hcl	Memantine Hcl	378	28,887	$13,347
Donepezil Hcl	Donepezil Hcl	528	41,344	$6,396
Levetiracetam	Levetiracetam	108	7,217	$3,181
Rivastigmine	Rivastigmine Tartrate	17	1,530	$2,894

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$801	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrea T. Dellaria, MD?

Tedicare shows public-source Medicare data for Andrea T. Dellaria, MD (NPI 1982036182), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrea T. Dellaria, MD have ACO affiliation data?

Andrea T. Dellaria, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Andrea T. Dellaria, MD?

Andrea T. Dellaria, MD is linked to NORTHWEST NEUROLOGY, LTD (billing NPI 1427094077) in the available physician profile data.

Does Andrea T. Dellaria, MD have Open Payments data?

Andrea T. Dellaria, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.